Does BETAXOLOL Cause Condition aggravated? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Condition aggravated have been filed in association with BETAXOLOL (Betoptic S). This represents 1.1% of all adverse event reports for BETAXOLOL.
7
Reports of Condition aggravated with BETAXOLOL
1.1%
of all BETAXOLOL reports
1
Deaths
2
Hospitalizations
How Dangerous Is Condition aggravated From BETAXOLOL?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BETAXOLOL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BETAXOLOL Cause?
Treatment failure (111)
Hypersensitivity (85)
Fall (66)
Drug ineffective (51)
Asthma (45)
Cardiac disorder (45)
Dizziness (42)
Bradycardia (38)
Dyspnoea (38)
Glaucoma (38)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which BETAXOLOL Alternatives Have Lower Condition aggravated Risk?
BETAXOLOL vs BETHANECHOL
BETAXOLOL vs BEVACIZUMAB
BETAXOLOL vs BEVACIZUMAB-AWWB
BETAXOLOL vs BEVACIZUMAB-BVZR
BETAXOLOL vs BEVACIZUMAB-MALY